Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,424 | 20,323 | 27,078 | 34,649 | 42,879 |
| TOTAL | $46,536 | $22,649 | $29,239 | $37,598 | $46,303 |
| Non-Current Assets | |||||
| PPE Net | 916 | 681 | 704 | 807 | 753 |
| Other Non-Current Assets | 662 | 716 | 603 | 614 | 672 |
| TOTAL | $1,578 | $1,397 | $1,307 | $1,421 | $1,425 |
| Total Assets | $48,114 | $24,046 | $30,546 | $39,019 | $47,728 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,310 | 2,400 | 3,139 | 5,259 | 3,890 |
| Accrued Expenses | 3,306 | 4,931 | 4,230 | 3,359 | 5,817 |
| TOTAL | $24,831 | $7,331 | $7,369 | $8,618 | $9,707 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,215 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 62 | 93 | 124 | 147 |
| TOTAL | $9,421 | $62 | $93 | $124 | $147 |
| Total Liabilities | $34,252 | $7,393 | $7,462 | $8,742 | $9,854 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,215 | 12,215 | 12,129 | 12,127 | 12,127 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -120,271 | -116,001 | -108,215 | -99,682 | -90,758 |
| TOTAL | $13,862 | $16,653 | $23,084 | $30,277 | $37,874 |
| Total Liabilities And Equity | $48,114 | $24,046 | $30,546 | $39,019 | $47,728 |